The Master of Science in Medical Products Regulatory Affairs is a pioneering programme designed to strengthen Africa’s regulatory capacity in the oversight of medicines, vaccines, medical devices, and other health products. With only eight African countries (two from the EAC) achieving WHO Maturity Level 3 (as of 2024), there is an urgent need for skilled regulatory professionals to ensure the safety, quality, and efficacy of medical products. This programme, the first of its kind in the EAC, addresses critical gaps in regulatory workforce capacity, policy development, and harmonization efforts—key factors in advancing Africa’s healthcare systems.

Programme Aim
The programme aims to train a new generation of regulatory experts who can:

• Apply global regulatory standards to medicines, vaccines, biologics, medical devices, and other health products.
• Support regulatory harmonization in line with the African Medicines Agency (AMA), AfCFTA, and EAC initiatives.
• Enhance market surveillance, pharmacovigilance, and compliance to ensure public health protection.
• Drive innovation while maintaining rigorous safety and efficacy assessments.

Why Choose This Programme?

• Address a Critical Skills Gap – Become part of Africa’s growing regulatory workforce.
• Align with Continental Priorities – Contribute to AMA, AfCFTA, and regional regulatory harmonization.
• Industry-Relevant Expertise – Gain hands-on training in drug approval, quality control, and compliance.
• Career Opportunities – Work in national regulatory agencies, pharmaceutical firms, and global health organizations.
• Pioneering Programme – First MSc in Regulatory Affairs in the East African Community.